Small Molecule Therapeutics for Schizophrenia (2015)

Small Molecule Therapeutics for Schizophrenia (2015)

Front Cover1. Antipsychotics and the Dopamine–Serotonin Connection
Bart A. Ellenbroek and Andrea M. Cesura
2. GlyT-1 Inhibitors: From Hits to Clinical Candidates
Roderick A. Porter and Lee A. Dawson
3. Metabotropic Glutamate Receptor 2 Activators
Jose´ M. Cid, Andre´s A. Trabanco, and Hilde Lavreysen
4. Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders
Theresa Williams, Marlene A. Jacobson, Mikhail Kalinichev, and Jean-Philippe Rocher
5. Muscarinic Acetylcholine Receptor Activators
Takaaki Sumiyoshi and Takeshi Enomoto
6. Nicotinic Acetylcholine Receptor Modulators
Anatoly Mazurov and Daniel Yohannes
7. The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia
Jamison B. Tuttle and Bethany L. Kormos
Index
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s